510(k) K210258

NovoFine by Novo Nordisk, Inc. — Product Code FMI

K210258 is an FDA 510(k) premarket notification submitted by Novo Nordisk, Inc. for the device "NovoFine". The FDA issued a decision of Substantially Equivalent on June 23, 2021. The device falls under product code FMI (Needle, Hypodermic, Single Lumen), a Class II device regulated under 21 CFR 880.5570. Novo Nordisk, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
June 23, 2021
Date Received
February 1, 2021
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Needle, Hypodermic, Single Lumen
Device Class
Class II
Regulation Number
880.5570
Review Panel
HO
Submission Type